These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267 [TBL] [Abstract][Full Text] [Related]
5. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1. Bowen R; Haslam RJ J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604 [TBL] [Abstract][Full Text] [Related]
6. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1). Cerneca F; de Luyk S; Radillo O; Simeone R; Mangiarotti M Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of phorbol 12-myristate 13-acetate and prostaglandin E1 on calcium regulation in human platelets. Yoshida K; Stark F; Nachmias VT Biochem J; 1988 Jan; 249(2):487-93. PubMed ID: 2829859 [TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH; Haslam RJ Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060 [TBL] [Abstract][Full Text] [Related]
9. Refractoriness of platelets to prostaglandins after infusion in rabbits. Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353 [TBL] [Abstract][Full Text] [Related]
10. [Effects of prostaglandin E1 and dibutyryl cyclic AMP on hemodynamics after cardiopulmonary bypass in valve replacement surgery]. Sumiyoshi N; Kawachi S; Oishi K; Tsushima K; Nakatani T; Imanishi T; Matsuda M; Hirose T; Tagami D Masui; 1992 Apr; 41(4):532-8. PubMed ID: 1315879 [TBL] [Abstract][Full Text] [Related]
11. Compartive behavioral effects of dibutyryl cyclic AMP and prostaglandin E1 in mice. Weiner M; Olson JW Prostaglandins; 1975 Jun; 9(6):927-43. PubMed ID: 169552 [TBL] [Abstract][Full Text] [Related]
12. Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets. Ofuji M; Kaiya H; Nozaki M; Tsurumi K Life Sci; 1989; 45(22):2135-40. PubMed ID: 2557518 [TBL] [Abstract][Full Text] [Related]
13. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1. Chirkov YY; Chirkova LP; Sage RE; Horowitz JD J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342 [TBL] [Abstract][Full Text] [Related]
14. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets. Williams KA; Murphy W; Haslam RJ Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206 [TBL] [Abstract][Full Text] [Related]
15. Effects of dibutyryl cyclic adenosinemonophosphate and prostaglandin E1 on platelet aggregation and shape changes. Wang TY; Hussey CV; Garancis JC Am J Clin Pathol; 1977 Apr; 67(4):362-7. PubMed ID: 192067 [TBL] [Abstract][Full Text] [Related]
16. Human platelet secretion and aggregation induced by calcium ionophores. Inhibition by PGE1 and dibutyryl cyclic AMP. Feinstein MB; Fraser C J Gen Physiol; 1975 Nov; 66(5):561-81. PubMed ID: 172596 [TBL] [Abstract][Full Text] [Related]
18. Dibutyryl cyclic AMP resistant MDCK cells in serum free medium have reduced cyclic AMP dependent protein kinase activity and a diminished effect of PGE1 on differentiated function. Devis PE; Grohol SH; Taub M J Cell Physiol; 1985 Oct; 125(1):23-35. PubMed ID: 2995425 [TBL] [Abstract][Full Text] [Related]
19. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP. Oda A; Druker BJ; Smith M; Salzman EW Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480 [TBL] [Abstract][Full Text] [Related]
20. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eigenthaler M; Nolte C; Halbrügge M; Walter U Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]